Cytopathic hypoxia and sepsis: Is mitochondrial dysfunction pathophysiologically important or just an epiphenomenon

Pediatric Critical Care Medicine

Volumn 16, Issue 1, 2015, Pages 89-91

  Fink, Mitchell P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

adenosine triphosphate; mitochondria; polarization; respiration

Indexed keywords

ADENOSINE TRIPHOSPHATE;

CELLS BY BODY ANATOMY; DISEASE SEVERITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EDITORIAL; HUMAN; HYPOXIA; MEMBRANE POLARIZATION AND DEPOLARIZATION; MITOCHONDRIAL RESPIRATION; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS; SEPTIC SHOCK; BLOOD; FEMALE; MALE; METABOLISM; MITOCHONDRION; MONONUCLEAR CELL;

FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MITOCHONDRIA; MITOCHONDRIAL DISEASES; SHOCK, SEPTIC;

EID: 84921458801     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/PCC.0000000000000299     Document Type: Editorial

References (24)

1. Mongardon N, Dyson A, Singer M: Is MOF an outcome parameter or a transient, adaptive state in critical illness? Curr Opin Crit Care 2009; 15:431-436
2. Fink MP: Bench-To-bedside review: Cytopathic hypoxia. Crit Care 2002; 6:491-499
3. Levy RJ, Vijayasarathy C, Raj NR, et al: Competitive and noncompeti-Tive inhibition of myocardial cytochrome C oxidase in sepsis. Shock 2004; 21:110-114
4. Vanasco V, Saez T, Magnani ND, et al: Cardiac mitochondrial biogenesis in endotoxemia is not accompanied by mitochondrial function recovery. Free Radic Biol Med 2014; 77C:1-9
5. Crouser ED, Julian MW, Dorinsky PM: Ileal VO(2)-O(2) alterations induced by endotoxin correlate with severity of mitochondrial injury. Am J Respir Crit Care Med 1999; 160:1347-1353
6. King CJ, Tytgat S, Delude RL, et al: Ileal mucosal oxygen consumption is decreased in endotoxemic rats but is restored toward normal by treatment with aminoguanidine. Crit Care Med 1999; 27:2518-2524
7. Lowes DA, Webster NR, Murphy MP, et al: Antioxidants that protect mitochondria reduce interleukin-6 and oxidative stress, improve mito-chondrial function, and reduce biochemical markers of organ dysfunction in a rat model of acute sepsis. Br J Anaesth 2013; 110:472-480
8. Brealey D, Karyampudi S, Jacques TS, et al: Mitochondrial dysfunction in a long-Term rodent model of sepsis and organ failure. Am J Physiol Regul Integr Comp Physiol 2004; 286:R491-R497
9. Peruchi BB, Petronilho F, Rojas HA, et al: Skeletal muscle electron transport chain dysfunction after sepsis in rats. J Surg Res 2011; 167:e333-e338
10. Brealey D, Brand M, Hargreaves I, et al: Association between mito-chondrial dysfunction and severity and outcome of septic shock. Lancet 2002; 360:219-223
11. Fredriksson K, Hammarqvist F, Strigård K, et al: Derangements in mitochondrial metabolism in intercostal and leg muscle of critically ill patients with sepsis-induced multiple organ failure. Am J Physiol Endocrinol Metab 2006; 291:E1044-E1050
12. Protti A, Fortunato F, Caspani ML, et al: Mitochondrial changes in platelets are not related to those in skeletal muscle during human septic shock. PLoS One 2014; 9:e96205
13. Fredriksson K, Fläring U, Guillet C, et al: Muscle mitochondrial activity increases rapidly after an endotoxin challenge in human volunteers. Acta Anaesthesiol Scand 2009; 53:299-304
14. Sjövall F, Morota S, Hansson MJ, et al: Temporal increase of platelet mitochondrial respiration is negatively associated with clinical outcome in patients with sepsis. Crit Care 2010; 14:R214
15. Sjövall F, Morota S, Frostner EÅ, et al: Cytokine and nitric oxide levels in patients with sepsis-Temporal evolvement and relation to platelet mitochondrial respiratory function. PLoS One 2014; 9:e103756
16. Gründler K, Angstwurm M, Hilge R, et al: Platelet mitochondrial membrane depolarization refects disease severity in patients with sepsis and correlates with clinical outcome. Crit Care 2014; 18:R31
17. Japiassú AM, Santiago AP, d'Avila JC, et al: Bioenergetic failure of human peripheral blood monocytes in patients with septic shock is mediated by reduced F1Fo adenosine-5'-Triphosphate synthase activity. Crit Care Med 2011; 39:1056-1063
18. Adrie C, Bachelet M, Vayssier-Taussat M, et al: Mitochondrial membrane potential and apoptosis peripheral blood monocytes in severe human sepsis. Am J Respir Crit Care Med 2001; 164:389-395
19. Belikova I, Lukaszewicz AC, Faivre V, et al: Oxygen consumption of human peripheral blood mononuclear cells in severe human sepsis. Crit Care Med 2007; 35:2702-2708
20. Garrabou G, Morén C, López S, et al: The effects of sepsis on mitochondria. J Infect Dis 2012; 205:392-400
21. Weiss SL, Selak MA, Tuluc F, et al: Mitochondrial Dysfunction in Peripheral Blood Mononuclear Cells in Pediatric Septic Shock. Pediatr Crit Care Med 2015; 16:e4-e12
22. Vanhorebeek I, De Vos R, Mesotten D, et al: Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet 2005; 365:53-59
23. Macias CA, Chiao JW, Xiao J, et al: Treatment with a novel hemi-gramicidin-TEMPO conjugate prolongs survival in a rat model of lethal hemorrhagic shock. Ann Surg 2007; 245:305-314
24. Szeto HH: First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. Br J Pharmacol 2014; 171:2029-2050